Podcast 41 of our TechLaw podcast series sees David Bell, Director at Hampleton Partners, leading M&A and corporate finance consultancy for companies with technology at their core, and DLA Piper Partner, Mark O’Conor, engage in an exciting conversation on the current innovations in HealthTech, as well as a futuristic outlook on the industry. Key highlights include the benefits of software as a medical device, macro factors influencing innovation and investment opportunities.
Join David and Mark at our fifth European Technology Summit on the 5th October 2021 where they will be resuming this conversation. Register at https://www.dlapipertechsummit.com/european/?utm_source=soundcloud&utm_medium=social&utm_campaign=tech-summit&utm_term=europe&utm_content=tech-summit
Join David and Mark at our fifth European Technology Summit on the 5th October 2021 where they will be resuming this conversation. Register at https://www.dlapipertechsummit.com/european/?utm_source=soundcloud&utm_medium=social&utm_campaign=tech-summit&utm_term=europe&utm_content=tech-summit
See omnystudio.com/listener for privacy information.
Fler avsnitt av DLA Piper TechLaw Podcast Series
Visa alla avsnitt av DLA Piper TechLaw Podcast SeriesDLA Piper TechLaw Podcast Series med DLA Piper finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
